Proteogenomic characterization of human colon and rectal cancer
Open accessAbstract
Extensive genomic characterization of human cancers presents the problem of inference from genomic abnormalities to cancer phenotypes. To address this problem, we analysed proteomes of colon and rectal tumours characterized previously by The Cancer Genome Atlas (TCGA) and perform integrated proteogenomic analyses. Somatic variants displayed reduced protein abundance compared to germline variants. Messenger RNA transcript abundance did not reliably predict protein abundance differences between tumours. Proteomics identified five proteomic subtypes in the TCGA cohort, two of which overlapped with the TCGA 'microsatellite instability/CpG island methylation phenotype' transcriptomic subtype, but had distinct mutation, methylation and protein expression patterns associated with different clinical outcomes. Although copy number alterations showed strong cis- and trans-effects on mRNA abundance, relatively few of these extend to the protein level. Thus, proteomics data enabled prioritization of candidate driver genes. The chromosome 20q amplicon was associated with the largest global changes at both mRNA and protein levels; proteomics data highlighted potential 20q candidates, including HNF4A (hepatocyte nuclear factor 4, alpha), TOMM34 (translocase of outer mitochondrial membrane 34) and SRC (SRC proto-oncogene, non-receptor tyrosine kinase). Integrated proteogenomic analysis provides functional context to interpret genomic abnormalities and affords a new paradigm for understanding cancer biology.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 13 cited sources checked · 0 supported · 0 flagged
- Findingown data
CNA-protein correlations are much weaker than CNA-mRNA correlations.
“In contrast, the diagonal pattern was much weaker for CNA-protein correlations (Fig. 3b).”
Quote in the paperNot a substantial claim - Findingown data
The same trend of higher correlations in focal regions was not observed for focal deletion regions.
“However, the same trend was not observed for genes in the focal deletion regions.”
Quote in the paperSubstantial claim - Findingown data
CNA-mRNA correlations were significantly higher than CNA-protein correlations for genes in focal amplification, focal deletion, and non-focal regions.
“CNA-mRNA correlations were significantly higher than CNA-protein correlations for genes in all three groups (p<1.0 × 10-10, KS test).”
- Also stated in: § Extended Data · plain
“CNA-mRNA correlations were significantly higher than CNA-protein correlations for genes in any of the three groups.”
Quote in the paperSubstantial claim - Also stated in: § Extended Data · plain
- Findingown data
Genes in focal amplification regions had significantly higher CNA-mRNA and CNA-protein correlations than genes in non-focal regions.
“genes in the focal amplification regions showed significantly higher CNA-mRNA and CNA-protein correlations than genes in the non-focal regions (p=4.4 × 10-4 and 0.02, respectively, KS test).”
Quote in the paperSubstantial claim - Findingown data
Somatic variants had lower protein abundance than germline/dbSNP-supported variants.
“somatic variants exerted a significantly stronger negative impact on protein abundance than did dbSNP-supported variants (p<2.2 × 10-16, Kolmogorov-Smirnov (KS) test, Fig. 1d, Supplementary Methods 5.5).”
Quote in the paperSubstantial claim
- Findingown data
Chromosomes 20q, 18, 16, 13, and 7 contained the five strongest trans-acting CNA hot spots driving global mRNA abundance variation.
“Chromosomes 20q, 18, 16, 13 and 7 contained the five strongest hot spots driving global mRNA abundance variation.”
Quote in the paperSubstantial claim - Findingown data
The fraction of variants with impact score below -2 was twice as high for somatic variants as for dbSNP-supported variants.
“The percentage of variants with an impact score of less than −2 was doubled for somatic variants compared to dbSNP-supported variants (p<2.2 × 10-16, Chi-squared test, Fig. 1d).”
Quote in the paperNot a substantial claim - Findingown data
The average Spearman correlation between mRNA and protein variation across tumors was 0.23.
“The average Spearman’s correlation between mRNA and protein variation was 0.23”
Quote in the paperSubstantial claim - Findingown data
Copy number alterations have strong cis-effects on mRNA abundance.
“Examination of the matrix visualizing significant CNA-mRNA correlations (multiple-test adjusted p value < 0.01) revealed strong positive correlations along the diagonal (Fig. 3a), suggesting strong cis-effects of CNAs on mRNA abundance.”
Quote in the paperSubstantial claim - Findingown data
Genes with stable mRNA and stable protein tend to have higher mRNA-protein correlation than genes with unstable mRNA and unstable protein.
“We also found that genes with stable mRNA and stable protein tend to have higher mRNA-protein correlation than those with unstable mRNA and unstable protein (p = 5.27 × 10-6, two-sided Wilcoxon rank-sum test, Supplementary Methods 7.6, Extended Data Fig. 6b).”
Quote in the paperSubstantial claim - Findingown data
Stage II tumors were significantly enriched in proteomic subtype C.
“We also examined the association between the subtype classification and clinical features and found only that stage II tumors were significantly enriched in subtype C (multiple-test adjusted p value < 0.05, Supplementary Table 11).”
Quote in the paperNot a substantial claim - Findingown data
Supervised analyses at the individual protein level for 13 clinical and genomic features identified few significant protein effects, except for hypermutation status, MSI status, and 18q loss.
“Supervised statistical analyses at the individual protein level for 13 clinical and genomic features also identified few, if any significant protein effects of these features, except for hypermutation status, MSI status, and 18q loss (Supplementary Table 12)”
Quote in the paperSubstantial claim - Findingown data
The 20q amplification was associated with the largest global changes in both mRNA and protein levels in univariate analysis.
“The 20q amplification was associated with the largest global changes in both mRNA and protein levels in this univariate analysis.”
Quote in the paperSubstantial claim - Findingown data
Reanalysis of HNF4A shRNA knockdown data from the Achilles project showed that CRC cell dependency on HNF4α correlated significantly with HNF4A amplification level.
“Upon reanalysis of the HNF4A shRNA knockdown data for CRC cell lines from the Achilles project21, we found that the dependency of CRC cells on HNF4α correlated significantly with the amplification level of HNF4A (Supplementary Methods 8.3, Extended Data Fig. 8)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] Cheung, H. W. et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc. Natl Acad. Sci. USA 108, 12372–12377 (2011) source
Not checked in the free run.
- Findingnone given
The remaining three proteomic subtypes were associated with chromosomal instability (CIN).
“The remaining three subtypes were associated with CIN, another well-accepted genetic property of CRC.”
Quote in the paperSubstantial claim - Findingown data
These hot spots were also strongest at the protein level.
“These hot spots also were strongest at the protein level.”
Quote in the paperSubstantial claim - Findingown data
Statistically significant association with hypermutation, MSI-high, POLE, and BRAF features was observed only for subtype B.
“However, statistically significant association with these features was only observed for subtype B (multiple-test adjusted p value < 0.05).”
Quote in the paperSubstantial claim - Findingown data
The same conclusion about 20q was reached with regularized multivariate regression (remMap).
“The same conclusion was reached with a regularized multivariate regression analysis method, remMap18”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Peng, J. et al. Regularized multivariate regression for identifying master predictors with application to integrative genomics study of breast cancer. Annals Applied Statistics 4, 53–77 (2010) source
Not checked in the free run.
- Findingown data
Genes involved in response to wounding were significantly enriched in the up-signature of subtype C.
“Genes involved in “response to wounding” were significantly enriched in the up-signature of subtype C (multiple-test adjusted p value < 2.2 × 10-16, Fisher’s exact test).”
Quote in the paperSubstantial claim - Findingown data
All CRC subtypes displayed more than 2,000 (>60%) significant protein abundance differences compared to normal colon.
“As shown in Extended Data Figure 10a, all CRC subtypes displayed more than 2,000 (>60%) significant protein abundance differences compared to normal colon.”
Quote in the paperNot a substantial claim - Findingown data
The down-signature enriched module III included the E-cadherin (CDH1)-β-catenin (CTNNB1)-α-catenin (CTNNA1) complex.
“Notably, the down-signature enriched module (III) included the E-cadherin (CDH1)-β-catenin (CTNNB1)-α-catenin (CTNNA1) complex (Extended Data Fig. 10c, 10e).”
Quote in the paperSubstantial claim - Findingown data
The most significantly up-regulated network module included collagens (COL1A1, COL3A1) and extracellular matrix glycoproteins (FN1, BGN, FBN1, FBN2).
“Moreover, proteins in the most significantly up-regulated network module (Extended Data Fig. 10d, 10f) included collagens (COL1A1 and COL3A1) and extracellular matrix glycoproteins (FN1, BGN, FBN1, and FBN2) that also are markers of EMT34, 35.”
Quote in the paperSubstantial claim - Findingown data
Relaxing the PSM false discovery rate from 0.1% to 1% for confidently identified proteins raised spectral counts from 4,896,831 to 6,299,756, an increase of 29%.
“This strategy led to increased spectral counts from 4,896,831 to 6,299,756, a 29% increase.”
Quote in the paperNot a substantial claim - Findingown data
Subtype signature proteins are not randomly distributed in the protein-protein interaction network.
“These proteins are not randomly distributed in the network.”
Quote in the paperNot a substantial claim - Findingown data
Genes in focal amplification regions showed the highest CNA-mRNA and CNA-protein correlations among the three groups.
“Moreover, genes in the focal amplification regions showed the highest level of CNA-mRNA and CNA-protein correlations among the three groups of genes.”
Quote in the paperNot a substantial claim - Findingown data
shRNAs simultaneously targeting both P1- and P2-HNF4α had a primarily negative impact on cell proliferation.
“whereas shRNAs simultaneously targeting both P1- and P2- HNF4α showed a primarily negative impact on cell proliferation (c,d).”
Quote in the paperNot a substantial claim - Findingown data
The P1-HNF4α-specific shRNA had mixed impacts on colon cancer cell proliferation.
“The P1- HNF4α specific shRNA showed mixed impacts (b)”
Quote in the paperNot a substantial claim - Findingown data
The rescued peptide-spectrum matches had a median PSM false discovery rate score below 0.2%.
“Rescued PSMs are of high quality with a median PSM FDR score of less than 0.2%, indicating the maintained integrity of the data set.”
Quote in the paperNot a substantial claim - Interpretationown data
Many CNA-driven mRNA increases do not translate into increased protein abundance.
“On the other hand, many CNA-driven mRNA level increases do not translate into increased abundance of the corresponding proteins.”
Quote in the paperSubstantial claim - Interpretationown data
mRNA transcript abundance does not reliably predict protein abundance differences between tumors.
“mRNA transcript abundance did not reliably predict protein abundance differences between tumors.”
Quote in the paperSubstantial claim - Interpretationown data
The correlation between HNF4α dependency and HNF4A amplification may partially explain contradictory roles reported for HNF4α in CRC.
“which may partially explain the contradictory roles reported for HNF4α in CRC.”
Quote in the paperSubstantial claim - Interpretationown data
HNF4α dependency might be particularly associated with the subset of tumors or cells with HNF4A amplification.
“This result, together with our reanalysis of shRNA knockdown data from the Achilles project (Extended Data Fig. 8), suggest that HNF4α dependency might be particularly associated with the subset of tumors or cells with HNF4A amplification.”
Quote in the paperSubstantial claim - Interpretationcitation
Most hot spot-related transcript changes did not propagate to the protein level, presumably due to buffering of protein abundance by post-transcriptional regulation.
“Most hot spot-related transcript changes did not propagate to the protein level, presumably reflecting buffering of protein abundance by post-transcriptional regulation16, 17.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [16] Foss, E. J. et al. Genetic basis of proteome variation in yeast. Nature Genet. 39, 1369–1375 (2007) source
Not checked in the free run.
- cites [17] Fu, J. et al. System-wide molecular evidence for phenotypic buffering in Arabidopsis. Nature Genet. 41, 166–167 (2009) source
Not checked in the free run.
- Interpretationreasoning
The proteomic subtypes identified by unsupervised clustering captured the major proteome variations across the tumors.
“suggesting that the proteomic subtypes identified by the unsupervised clustering analysis captured the major proteome variations across the tumors.”
Quote in the paperSubstantial claim - Interpretationreasoning
Proteomic measurements can help prioritize genes in amplified regions for further examination.
“Because significant CNA-protein correlations identify amplified sequences that translate to high protein abundance, proteomic measurements can help prioritize genes in amplified regions for further examination.”
Quote in the paperSubstantial claim - Study design and conductown data
A low cross-validation error rate of 3.8% demonstrated good generalizability of the proteomic subtypes and their signature proteins.
“Although a full validation of the proteomic subtypes and protein signatures for the subtypes will require proteomic profiling data from an independent tumor cohort, a low cross-validation error rate of 3.8% demonstrated good generalizability of the subtypes and their signature proteins (Supplementary Methods 11).”
Quote in the paperSubstantial claim - Interpretationown data
Combined mRNA and protein profiling data can identify potentially relevant genes in amplified chromosomal regions.
“Combined mRNA and protein profiling data can identify potentially relevant genes in amplified chromosomal regions.”
Quote in the paperSubstantial claim - Interpretationown data
The separation of the TCGA MSI/CIMP subtype into distinct proteotypes illustrates the unique potential of proteomics-based subtyping.
“The separation of the TCGA “MSI/CIMP” subtype into distinct proteotypes illustrates the unique potential of proteomics-based subtyping.”
Quote in the paperSubstantial claim - Interpretationown data
Protein abundance cannot be reliably predicted from DNA or RNA-level measurements.
“The data demonstrate that protein abundance cannot be reliably predicted from DNA or RNA-level measurements.”
Quote in the paperSubstantial claim - Premisecitation
These proteins are markers of EMT.
“Moreover, proteins in the most significantly up-regulated network module (Extended Data Fig. 10d, 10f) included collagens (COL1A1 and COL3A1) and extracellular matrix glycoproteins (FN1, BGN, FBN1, and FBN2) that also are markers of EMT34, 35.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34] Kiemer, A. K., Takeuchi, K. & Quinlan, M. P. Identification of genes involved in epithelial-mesenchymal transition and tumor progression. Oncogene 20, 6679–6688 (2001) source
Not checked in the free run.
- cites [35] Zeisberg, M. & Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 119, 1429–1437 (2009) source
Not checked in the free run.
- Study design and conductown data
Single amino acid variants identified in the TCGA shotgun data set were validated using parallel reaction monitoring analyses.
“Single amino acid variants (SAAVs) identified in the TCGA shotgun data set were validated using PRM analyses.”
Quote in the paperNot a substantial claim - Study design and conductown data
The consensus matrices show that the discovered clusters are robust to sampling variability (resampling 80% of samples) for cluster numbers k=2 to 8.
“The consensus matrices show the robustness of the discovered clusters to sampling variability (resampling 80% samples) for cluster numbers k = 2 to 8.”
Quote in the paperSubstantial claim - Interpretationown data
The true number of clusters was considered to be 7 because the change in area under the CDF was close to zero when k increased from 7 to 8.
“In this case, 7 was considered as ktrue because the change of the area under the CDF was close to zero when k increased from 7 to 8.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The area under the CDF increases markedly as k increases until the true number of clusters is reached.
- May combine two claims. 34
- The quote only partly states this claim. 2
- Classified as probably not a substantial claim. 3
May combine two claims.
Findingown dataIn individual samples, steady-state mRNA and protein abundance showed significant positive correlation, with an average correlation of 0.47.
“All samples showed significant positive mRNA-protein correlation (multiple-test adjusted p value < 0.01, Spearman’s correlation coefficient) and the average correlation between steady state mRNA and protein abundance in individual samples was 0.47 (Fig. 2a)”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataAcross tumors, 89% of genes had positive mRNA-protein correlation, but only 32% had statistically significant correlations.
“Although 89% of the genes showed a positive mRNA-protein correlation, only 32% had statistically significant correlations (Fig. 2b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataProteomic subtypes B and C both showed significant association with the TCGA MSI/CIMP subtype, but differ considerably at genomic, epigenomic, and proteomic levels.
“Proteomic subtypes B and C both showed significant association with the TCGA subtype “MSI/CIMP” (Fig. 4b, Supplementary Table 11); however, they differ considerably at genomic, epigenomic, and proteomic levels (Fig. 4b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataConsensus clustering identified five major proteomic subtypes in the tumor cohort, with 15, 9, 25, 11, and 19 cases in subtypes A through E.
“Using the Consensus Clustering24 method (Supplementary Methods 9.1–9.2, Extended Data Fig. 9), we identified five major proteomic subtypes in this tumor cohort, with 15, 9, 25, 11, and 19 cases in subtypes A through E, respectively (Fig. 4a–b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24] Monti, S., Tamayo, P., Mesirov, J. & Golub, T. R. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91–118 (2003) source
Not checked in the free run.
May combine two claims.
Findingown dataHNF4α abundance was significantly higher in subtype E tumors than in normal colon samples, but not significantly up-regulated in other subtypes.
“HNF4α abundance was significantly higher in subtype E tumors compared to normal colon samples (multiple-test adjusted p value = 1.09 × 10-6, two-sided Wilcoxon rank-sum test); however, significant up-regulation of HNF4α was not observed for other subtypes (Supplementary Methods 10).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataProteomic subtype C, but not subtype B, showed enriched overlap with the Stem-like subtype and the CCS3 subtype.
“Proteomic subtype C, but not subtype B, showed enriched overlap with the “Stem-like” subtype described by Sadanandam et al.27 and the “CCS3” subtype described by De Sousa et al.26.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [27] Sadanandam, A. et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nature Med. 19, 619–625 (2013) source
Not checked in the free run.
- cites [26] De Sousa E Melo, F. et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nature Med. 19, 614–618 (2013) source
Not checked in the free run.
May combine two claims.
Findingown dataAlmost all hypermutated and MSI-high tumors, as well as tumors with POLE and BRAF mutations, were included in proteomic subtypes B and C.
“Almost all hypermutated and MSI-high tumors were included in subtypes B and C, as well as tumors with POLE and BRAF mutations.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSubtype E was associated with HNF4A amplification and relatively higher HNF4α protein abundance.
“Interestingly, subtype E was also associated with HNF4A amplification and relatively higher abundance of HNF4α protein (Fig. 4d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSubtype B was significantly associated with the TCGA CIMP-H methylation subtype, while subtype C was significantly associated with a non-CIMP subtype (cluster 4).
“Moreover, whereas subtype B was significantly associated with the TCGA CIMP-H (CIMP-high) methylation subtype, subtype C was significantly associated with a non-CIMP subtype (cluster 4).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAmong 79 genes in the 20q region with quantifiable protein measurements, 67 (85%) showed significant CNA-mRNA correlation, but only 40 (51%) showed significant CNA-protein correlation.
“Among the 79 genes in the 20q region with quantifiable protein measurements, 67 (85%) showed significant CNA-mRNA correlation, but only 40 (51%) showed significant CNA-protein correlation (multiple-test adjusted p value < 0.01, Spearman’s correlation coefficient, Supplementary Table 10).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationSubtype E was significantly associated with both TP53 mutations and 18q loss.
“In particular, subtype E was significantly associated with both TP53 mutations and 18q loss, genomic features frequently associated with CIN tumors25.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Fearon, E. R. Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 6, 479–507 (2011) source
Not checked in the free run.
May combine two claims.
Findingown dataSubtype B lacked TP53 mutations and chromosome 18q loss.
“Another unique feature of subtype B was the lack of TP53 mutations and chromosome 18q loss.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datamRNA and protein levels were modestly correlated, but over two thirds of these correlations were not statistically significant in the TCGA tumor set.
“mRNA and protein levels were modestly correlated, as earlier cell and animal model studies suggest36, but over two thirds of these correlations were not statistically significant in the TCGA tumor set.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Vogel, C. & Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nature Rev. Genet. 13, 227–232 (2012) source
Not checked in the free run.
May combine two claims.
Findingown dataFour network modules were enriched with genes in the up-signature of subtype C, and two modules were enriched with genes in the down-signature.
“Four network modules were enriched with genes in the up-signature for subtype C, whereas two modules were enriched with genes in the down-signature (multiple-test adjusted p value < 0.01, Fisher’s exact test, Extended Data Fig. 10b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFour network modules (I, IV, V, VI) were significantly enriched with up-signature proteins and two modules (II and III) were significantly enriched with down-signature proteins (adjusted p < 0.01).
“Highlighted by red or blue arrows are four Network modules (I, IV, V, VI) significantly enriched with up-signature proteins and two modules (II and III) significantly enriched with down-signature proteins (adjusted p value < 0.01).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataProtein bins with spectral counts below 1.4 had clearly lower intraclass correlation coefficients, while the ICC curves began to converge when average spectral count exceeded 1.4.
“Protein bins with spectral counts less than 1.4 showed clearly lower ICC scores, whereas the ICC score curves started to converge when the average spectral count was greater than 1.4.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGenes with stable mRNA and stable protein had relatively higher mRNA-protein correlation, while genes with unstable mRNA and unstable protein had relatively lower mRNA-protein correlation.
“Genes with stable mRNA and stable protein showed relatively higher mRNA-protein correlation whereas those with unstable mRNA and unstable protein showed relatively lower mRNA-protein correlation.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe spectral count increase after relaxing the false discovery rate occurred for all 7,526 confidently identified proteins, with no protein showing a decrease.
“Spectral count plot of all 7,526 confidently identified proteins demonstrates the increase in the absolute number of spectra identified for each protein, but no decrease for any of the proteins.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFPKM-based transcript abundance estimates are independent of gene length, whereas RSEM-based estimates strongly correlate with gene length.
“FPKM measure is independent of gene length, whereas the RSEM measure strongly correlates with gene length.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA stronger negative impact of HNF4A shRNA on proliferation was associated with increased copy number, both for the P1-HNF4α-specific shRNA (p=0.04) and for all shRNAs (p=0.01).
“Moreover, a stronger negative impact was associated with increased copy number, both for the P1- HNF4α specific shRNA (p=0.04, Spearman’s correlation [r]) and for all shRNAs (p=0.01, Spearman’s correlation p-values for individual shRNAs summarized by the Fisher’s combined probability test).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn most scenarios, quantile normalization produced slightly higher intraclass correlation coefficients than global normalization, and both methods clearly outperformed NSAF normalization.
“In most scenarios, quantile normalization generated slightly higher ICC scores than global normalization, and both methods clearly outperformed the NSAF normalization.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataTRCN0000019193 specifically targets P1 promoter-driven HNF4α isoforms, whereas the other two shRNAs target both P1 and P2 isoforms.
“TRCN0000019193 specifically targets P1 promoter-driven isoforms, whereas the other two target both types of isoforms.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAmong 228,157 exons, 76% were expressed, but only 64% had an average coverage greater than 1.
“Among all 228,157 exons, 76% were expressed, but only 64% had an average coverage greater than 1.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataApproximately 54% of mutation positions were covered by RNA-Seq reads, and only 43% were covered by three or more reads.
“Approximately 54% of the mutation positions were covered by RNA-Seq reads and only 43% were covered by three or more reads.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataFocal amplifications have the strongest cis-effects on both mRNA and protein abundance, suggesting selection for high protein abundance may drive CNA in focal amplification regions.
“Therefore, focal amplifications have the strongest cis-effects on both mRNA and protein abundance, suggesting that selection for high protein abundance may drive CNA in regions of focal amplification.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataProteomic subtype B is associated with MSI-High and CIMP, but subtype C may have different biological underpinnings.
“These results clearly established the association between proteomic subtype B and MSI-High and CIMP, but suggest that subtype C might have different biological underpinnings.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningMany hot spot-associated protein level alterations occurred without corresponding mRNA alterations, suggesting independent effects at transcriptome and proteome levels.
“Notably, many hot spot-associated protein level alterations occurred in the absence of corresponding mRNA alterations, suggesting that the same trans-acting hot spot may exert independent effects at both the transcriptome and proteome levels.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThese data strengthen the association of subtype C with poor prognosis and relate it to EMT activation.
“These data strengthen the association of subtype C with poor prognosis and relate it to EMT activation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAlthough most CNAs in CRC drive mRNA abundance changes, relatively few translated to consistent changes in protein abundance.
“Although most CNAs in CRC drive mRNA abundance changes, relatively few translated to consistent changes in protein abundance.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe wound-response gene signature is a powerful predictor of poor clinical outcome in early stage breast cancers.
“The wound-response gene signature is a powerful predictor of poor clinical outcome in patients with early stage breast cancers29.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Chang, H. Y. et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc. Natl Acad. Sci. USA 102, 3738–3743 (2005) source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBecause Stem-like and CCS3 tumors have poor prognosis, proteomic subtype C may also be associated with poor prognosis.
“Interestingly, tumors with “Stem-like” and “CCS3” classifications both have poor prognosis, which suggests that proteome subtype C also may be associated with poor prognosis.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationDistinguishing subtype B from C through proteomics is important because MSI-High tumors typically have better prognosis.
“Therefore, the ability to distinguish subtype B from C through proteomics data is important, because MSI-High tumors typically have better prognosis25.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] Fearon, E. R. Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 6, 479–507 (2011) source
Not checked in the free run.
May combine two claims.
Interpretationown dataProteomics identified CRC subtypes similar to those detectable by transcriptome profiles, but further captured features not detectable in transcript profiles.
“Proteomics identified CRC subtypes similar to those detectable by transcriptome profiles, but further captured features not detectable in transcript profiles.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThis approach revealed the importance of chromosome 20q amplification and provided new insights into the role of HNF4α in CRC.
“This approach, which revealed the importance of chromosome 20q amplification and provided new insights into the role of HNF4α in CRC, can be broadly extended to understand roles of CNAs in other cancers.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
InterpretationreasoningThe enrichment of wound-response genes further links subtype C to poor prognosis.
“This result further links our subtype C to poor prognosis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenXenograft QC samples were run after every 5 colorectal tumor samples.
“Xenograft QC samples were run after every 5 colorectal tumor samples.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenNo selection criteria other than sample availability were applied for this study.
“No other selection criteria other than availability were applied for this study.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe rescued peptide-spectrum matches are of high quality and the integrity of the data set is maintained.
“Rescued PSMs are of high quality with a median PSM FDR score of less than 0.2%, indicating the maintained integrity of the data set.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The drivers underlying copy number alterations and transcriptional subtypes in colorectal cancer are largely unknown.
“The drivers underlying copy number alterations (CNAs) and transcriptional subtypes are largely unknown”
The paper relies on this without support.
Proteins link genotypes to phenotypes.
“Because proteins link genotypes to phenotypes, the Clinical Proteomic Tumor Analysis Consortium (CPTAC) is performing proteomic analyses of TCGA tumor specimens for selected cancer types.”
The authors state this as an assumption.
The area under the CDF increases markedly as k increases until the true number of clusters is reached.
“As k increases, the area under the CDF is hypothesized to increase markedly until k reaches the ktrue.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CPTAC applied standards and workflows to tumours previously genomically characterized by The Cancer Genome Atlas, pioneered the integration of proteomics with genomics to produce a more unified and comprehensive understanding of cancer biology, and implemented its transition into cancer clinical research studies.
“CPTAC applied these standards and workflows to tumours previously genomically characterized by The Cancer Genome Atlas. In doing so, CPTAC pioneered the integration of proteomics with genomics (i.e., proteogenomics) to produce a more unified and comprehensive understanding of cancer biology and implemented its transition into cancer clinical research studies96,104,105.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [104]
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179 · see citing works
Silhouettes: A graphical aid to the interpretation and validation of cluster analysis
Rousseeuw, P. J. (1987) · Journal of Computational and Applied Mathematics · doi:10.1016/0377-0427(87)90125-7 · Cited by 21,392 · see citing works
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455 · see citing works
Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551 · see citing works
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129 · see citing works
Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 11,930 · see citing works
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499 · see citing works
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,185 · see citing works
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950 · see citing works
Self-citationVogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · see citing works
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735 · see citing works
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · see citing works
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · see citing works
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784 · see citing works
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S. C. Y., Voduc, D. K., Vickery, T. L., Davies, S. R., Fauron, C. M. ‐., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,737 · see citing works
Self-citationSkyline: an open source document editor for creating and analyzing targeted proteomics experiments
MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697 · see citing works
Self-citationInsights into the regulation of protein abundance from proteomic and transcriptomic analyses
Vogel, C., & Marcotte, E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3185 · Cited by 4,195 · see citing works
A cross-platform toolkit for mass spectrometry and proteomics
Chambers, M., MacLean, B., Burke, R., Amodei, D., Ruderman, D., Neumann, S., Gatto, L., Fischer, B., Pratt, B. S., Egertson, J. D., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2377 · Cited by 4,038 · see citing works
Self-citationComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994 · see citing works
Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,469 · see citing works
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · see citing works
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R. J., Hastie, T. J., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,938 · see citing works
A Model for Random Sampling and Estimation of Relative Protein Abundance in Shotgun Proteomics
Liu, H., Sadygov, R. G., & Yates, J. R. (2004) · Analytical Chemistry · doi:10.1021/ac0498563 · Cited by 2,486 · see citing works
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · see citing works
Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116 · see citing works
Reich, M. M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., & Mesirov, J. P. (2006) · Nature Genetics · doi:10.1038/ng0506-500 · Cited by 2,035 · see citing works
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805 · see citing works
WebGestalt: an integrated system for exploring gene sets in various biological contexts
Zhang, B., Kirov, S. A., & Snoddy, J. R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki475 · Cited by 1,801 · see citing works
Self-citationWEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013
Wang, J., Duncan, D. T., Shi, Z., & Zhang, B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt439 · Cited by 1,502 · see citing works
Self-citationGlobal signatures of protein and mRNA expression levels
de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M., & Vogel, C. (2009) · Molecular BioSystems · doi:10.1039/b908315d · Cited by 1,248 · see citing works
Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics
Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L. D., Pierce, K. G., Mendoza, A. M., Sevinsky, J. R., Resing, K. A., & Ahn, N. G. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500084-mcp200 · Cited by 1,206 · see citing works
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,134 · see citing works
Self-citationStatistical Analysis of Membrane Proteome Expression Changes in Saccharomyces cerevisiae
Zybailov, B. L., Mosley, A. L., Sardiu, M. E., Coleman, M. K., Florens, L. A., & Washburn, M. P. (2006) · Journal of Proteome Research · doi:10.1021/pr060161n · Cited by 1,031 · see citing works
Chang, H. Y., Nuyten, D. S. A., Sneddon, J. B., Hastie, T., Tibshirani, R., Sørlie, T., Dai, H., He, Y. D., van't Veer, L. J., Bartelink, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409462102 · Cited by 981 · see citing works
Sadanandam, A., Lyssiotis, C. A., Homicsko, K., Collisson, E. A., Gibb, W. J., Wullschleger, S., Ostos, L. C. G., Lannon, W. A., Grotzinger, C., Del Rio, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3175 · Cited by 960 · see citing works
De Sousa E Melo, F., Wang, X., Jansen, M., Fessler, E., Trinh, A., de Rooij, L. P. M. H., de Jong, J. H., de Boer, O. J., van Leersum, R., Bijlsma, M. F., et al. (2013) · Nature Medicine · doi:10.1038/nm.3174 · Cited by 771 · see citing works
Self-citationComparative analysis of proteome and transcriptome variation in mouse
Ghazalpour, A., Bennett, B., Petyuk, V. A., Orozco, L., Hagopian, R., Mungrue, I. N., Farber, C. R., Sinsheimer, J., Kang, H. M., Furlotte, N., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001393 · Cited by 624 · see citing works
Li, S., Shen, D., Shao, J., Crowder, R. J., Liu, W., Prat, A., He, X., Liu, S., Hoog, J., Lu, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.022 · Cited by 623 · see citing works
Self-citationTabb, D. L., Fernando, C., & Chambers, M. (2007) · Journal of Proteome Research · doi:10.1021/pr0604054 · Cited by 548 · see citing works
Self-citationCorrelations between RNA and protein expression profiles in 23 human cell lines
Gry, M., Rimini, R., Strömberg, S., Asplund, A., Pontén, F., Uhlén, M., & Nilsson, P. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-365 · Cited by 520 · see citing works
Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer
Gallien, S., Duriez, E., Crone, C., Kellmann, M., Moehring, T., & Domon, B. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.019802 · Cited by 510 · see citing works
Activating SRC mutation in a subset of advanced human colon cancers
Irby, R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., & Yeatman, T. J. (1999) · Nature Genetics · doi:10.1038/5971 · Cited by 489 · see citing works
Kislinger, T., Cox, B., Kannan, A., Chung, C., Hu, P., Ignatchenko, A., Scott, M. S., Gramolini, A. O., Morris, Q., Hallett, M. T., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.044 · Cited by 482 · see citing works
Cheung, H. W., Cowley, G. S., Weir, B. A., Boehm, J. S., Rusin, S., Scott, J. A., East, A., Ali, L. D., Lizotte, P. H., Wong, T. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109363108 · Cited by 423 · see citing works
Detecting Differential and Correlated Protein Expression in Label-Free Shotgun Proteomics
Zhang, B., VerBerkmoes, N. C., Langston, M. A., Uberbacher, E. C., Hettich, R. L., & Samatova, N. F. (2006) · Journal of Proteome Research · doi:10.1021/pr0600273 · Cited by 394 · see citing works
Self-citationGenetic basis of proteome variation in yeast
Foss, E. J., Radulovic, D., Shaffer, S. A., Ruderfer, D. M., Bedalov, A., Goodlett, D. R., & Kruglyak, L. (2007) · Nature Genetics · doi:10.1038/ng.2007.22 · Cited by 358 · see citing works
Zybailov, B. L., Coleman, M. K., Florens, L. A., & Washburn, M. P. (2005) · Analytical Chemistry · doi:10.1021/ac050846r · Cited by 349 · see citing works
IDPicker 2.0: Improved Protein Assembly with High Discrimination Peptide Identification Filtering
Ma, Z.-Q., Dasari, S., Chambers, M., Litton, M. D., Sobecki, S. M., Zimmerman, L. J., Halvey, P. J., Schilling, B., Drake, P. M., Gibson, B. W., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr900360j · Cited by 328 · see citing works
Self-citationEMT is the dominant program in human colon cancer
Loboda, A., Nebozhyn, M. V., Watters, J. W., Buser, C. A., Shaw, P. M., Huang, P. S., Van't Veer, L., Tollenaar, R. A., Jackson, D. B., Agrawal, D., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-9 · Cited by 274 · see citing works
System-wide molecular evidence for phenotypic buffering in Arabidopsis
Fu, J., Keurentjes, J. J. B., Bouwmeester, H., America, T., Verstappen, F. W. A., Ward, J. L., Beale, M. H., de Vos, R. C. H., Dijkstra, M., Scheltema, R. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.308 · Cited by 265 · see citing works
Peng, J., Zhu, J., Bergamaschi, A., Han, W., Noh, D., Pollack, J. R., & Wang, P. (2010) · PubMed · doi:10.1214/09-aoas271supp · Cited by 232 · see citing works
Self-citationKim, S., Mischerikow, N., Bandeira, N., Navarro, J. D., Wich, L., Mohammed, S., Heck, A. J. R., & Pevzner, P. A. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.003731 · Cited by 226 · see citing works
Self-citationLicklider, L. J., Thoreen, C. C., Peng, J., & Gygi, S. P. (2002) · Analytical Chemistry · doi:10.1021/ac025529o · Cited by 218 · see citing works
Peng, J., Zhu, J., Bergamaschi, A., Han, W., Noh, D.-Y., Pollack, J. R., & Wang, P. (2010) · The Annals of Applied Statistics · doi:10.1214/09-aoas271 · Cited by 211 · see citing works
Self-citationiRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence
Turner, B., Razick, S., Turinsky, A. L., Vlasblom, J., Crowdy, E., Cho, E., Morrison, K., Donaldson, I. M., & Wodak, S. J. (2010) · Database · doi:10.1093/database/baq023 · Cited by 207 · see citing works
Protein Identification Using Customized Protein Sequence Databases Derived from RNA-Seq Data
Wang, X., Slebos, R. J. C., Wang, D., Halvey, P. J., Tabb, D. L., Liebler, D. C., & Zhang, B. (2012) · Journal of Proteome Research · doi:10.1021/pr200766z · Cited by 173 · see citing works
Self-citationHepatocyte Nuclear Factor 4α Is Essential for Embryonic Development of the Mouse Colon
Garrison, W. D., Battle, M. A., Yang, C., Kaestner, K. H., Sladek, F. M., & Duncan, S. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.003 · Cited by 166 · see citing works
Wang, X., & Zhang, B. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt543 · Cited by 162 · see citing works
Self-citationNing, K., Fermin, D., & Nesvizhskii, A. I. (2012) · Journal of Proteome Research · doi:10.1021/pr201052x · Cited by 145 · see citing works
Integrated genomic analyses of ovarian carcinoma
The Cancer Genome Atlas Research Network (2011) · Nature · doi:10.1038/nature10166 · Cited by 129 · see citing works
Genetic Variation Shapes Protein Networks Mainly through Non-transcriptional Mechanisms
Foss, E. J., Radulovic, D., Shaffer, S. A., Goodlett, D. R., Kruglyak, L., & Bedalov, A. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001144 · Cited by 103 · see citing works
Comparative Shotgun Proteomics Using Spectral Count Data and Quasi-Likelihood Modeling
Li, M., Gray, W., Zhang, H., Chung, C. H., Billheimer, D. D., Yarbrough, W. G., Liebler, D. C., Shyr, Y., & Slebos, R. J. C. (2010) · Journal of Proteome Research · doi:10.1021/pr100527g · Cited by 102 · see citing works
Self-citationDarsigny, M., Babeu, J., Seidman, E. G., Gendron, F., Levy, E. H., Carrier, J. C., Perreault, N., & Boudreau, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1697 · Cited by 90 · see citing works
Chellappa, K., Jankova, L., Schnabl, J. M., Pan, S., Brélivet, Y., Fung, C. L.-S., Chan, C., Dent, O. F., Clarke, S. J., Robertson, G. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106799109 · Cited by 83 · see citing works
GO-function: deriving biologically relevant functions from statistically significant functions
Wang, J., Zhou, X., Zhu, J., Gu, Y., Zhao, W., Zou, J., & Guo, Z. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr041 · Cited by 81 · see citing works
Self-citationIdentification of genes involved in epithelial-mesenchymal transition and tumor progression
Kiemer, A. K., Takeuchi, K., & Quinlan, M. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204872 · Cited by 77 · see citing works
NetGestalt: integrating multidimensional omics data over biological networks
Shi, Z., Wang, J., & Zhang, B. (2013) · Nature Methods · doi:10.1038/nmeth.2517 · Cited by 64 · see citing works
Self-citationDasari, S., Chambers, M., Martinez, M. A., Carpenter, K. L., Ham, A. L., Vega‐Montoto, L., & Tabb, D. L. (2012) · Journal of Proteome Research · doi:10.1021/pr200874e · Cited by 64 · see citing works
Self-citationZhou, J.-Y., Schepmoes, A., Zhang, X., Moore, R., Monroe, M. E., Lee, J. H., Camp, D., Smith, R. D., & Qian, W. (2010) · Journal of Proteome Research · doi:10.1021/pr100508p · Cited by 59 · see citing works
Proteomic analysis of oropharyngeal carcinomas reveals novel HPV‐associated biological pathways
Slebos, R. J. C., Jehmlich, N., Brown, B. T., Yin, Z., Chung, C. H., Yarbrough, W. G., & Liebler, D. C. (2012) · International Journal of Cancer · doi:10.1002/ijc.27699 · Cited by 54 · see citing works
Self-citationHalvey, P. J., Wang, X., Wang, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2488 · Cited by 49 · see citing works
Self-citationShimokawa, T., Matsushima, S., Tsunoda, T., et al. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.2.381 · Cited by 48 · see citing works
Inhibition of colorectal cancer by targeting hepatocyte nuclear factor‐4α
Schwartz, B., Algamas‐Dimantov, A., Hertz, R., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24041 · Cited by 47 · see citing works
Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer
Saandi, T., Baraille, F., Derbal-Wolfrom, L., et al. (2012) · Oncogene · doi:10.1038/onc.2012.401 · Cited by 47 · see citing works
Anomalous Features of EMT during Keratinocyte Transformation
Geiger, T., Sabanay, H., Kravchenko‐Balasha, N., Geiger, B., & Levitzki, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001574 · Cited by 46 · see citing works
Supporting tool suite for production proteomics
Ma, Z., Tabb, D. L., Burden, J., et al. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr544 · Cited by 36 · see citing works
Self-citationHNF4α: A New Biomarker in Colon Cancer?
Chellappa, K., Robertson, G. R., & Sladek, F. M. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.23 · Cited by 35 · see citing works
Proteomic Consequences of a Single Gene Mutation in a Colorectal Cancer Model
Halvey, P. J., Zhang, B., Coffey, R. J., Liebler, D. C., & Slebos, R. J. C. (2011) · Journal of Proteome Research · doi:10.1021/pr2009109 · Cited by 34 · see citing works
Self-citationKim, W. K., Park, M., Park, M., Kim, Y. J., Shin, N., Kim, H. K., You, K. T., & Kim, H. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0684 · Cited by 31 · see citing works
Liu, Q., Halvey, P. J., Shyr, Y., Slebos, R. J. C., Liebler, D. C., & Zhang, B. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.025783 · Cited by 29 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170 · see citing works
Self-citationProteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676 · see citing works
Self-citationmRNAs, proteins and the emerging principles of gene expression control
Buccitelli, C., & Selbach, M. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0258-4 · Cited by 1,243 · see citing works
Integrative omics for health and disease
Karczewski, K. J., & Snyder, M. P. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2018.4 · Cited by 1,158 · see citing works
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Gao, Q., Zhu, H., Dong, L., Shi, W., Chen, R., Song, Z., Huang, C., Li, J., Dong, X., Zhou, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.052 · Cited by 1,096 · see citing works
Self-citationIntegrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Zhang, H., Liu, T., Zhang, Z., Payne, S. H., Zhang, B., McDermott, J. E., Zhou, J.-Y., Petyuk, V. A., Chen, L., Ray, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.069 · Cited by 1,029 · see citing works
Self-citationDeep learning-based multi-omics integration robustly predicts survival in liver cancer
Chaudhary, K., Poirion, O. B., Lu, L., & Garmire, L. X. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0853 · Cited by 1,091 · see citing works
Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001 · see citing works
Self-citationProteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Vasaikar, S., Huang, C., Wang, X., Petyuk, V. A., Savage, S. R., Wen, B., Dou, Y., Zhang, Y., Shi, Z., Arshad, O. A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.030 · Cited by 799 · see citing works
Self-citationIntegrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., da Veiga Leprevost, F., Reva, B., Lih, T.-S. M., Chang, H.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.007 · Cited by 730 · see citing works
Self-citationSeyfried, N. T., Dammer, E. B., Swarup, V., Nandakumar, D., Duong, D. M., Yin, L., Deng, Q., Nguyen, T., Hales, C. M., Wingo, T., et al. (2017) · Cell Systems · doi:10.1016/j.cels.2016.11.006 · Cited by 477 · see citing works
Proteogenomic Characterization of Endometrial Carcinoma
Dou, Y., Kawaler, E. A., Cui Zhou, D., Gritsenko, M. A., Huang, C., Blumenberg, L., Karpova, A., Petyuk, V. A., Savage, S. R., Satpathy, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.026 · Cited by 485 · see citing works
Self-citationSingle-cell multiomics: technologies and data analysis methods
Lee, J., Hyeon, D. Y., & Hwang, D. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0420-2 · Cited by 524 · see citing works
Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer
Carethers, J. M., & Jung, B. H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.047 · Cited by 483 · see citing works
Genetics meets proteomics: perspectives for large population-based studies
Suhre, K., McCarthy, M. I., & Schwenk, J. M. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-0268-2 · Cited by 478 · see citing works
Deutsch, E. W., Mendoza, L., Shteynberg, D., Slagel, J., Sun, Z., & Moritz, R. L. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400164 · Cited by 342 · see citing works
Proteogenomic Characterization of Human Early-Onset Gastric Cancer
Mun, D.-G., Bhin, J., Kim, S., Kim, H., Jung, J. H., Jung, Y., Jang, Y. E., Park, J. M., Kim, H., Jung, Y., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.003 · Cited by 294 · see citing works
Self-citationIntegrated Omics of Metastatic Colorectal Cancer
Li, C., Sun, Y.-D., Yu, G.-Y., Cui, J.-R., Lou, Z., Zhang, H., Huang, Y., Bai, C.-G., Deng, L.-L., Liu, P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.002 · Cited by 297 · see citing works
Self-citationUnbiased spatial proteomics with single-cell resolution in tissues
Mund, A., Brunner, A.-D., & Mann, M. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.05.022 · Cited by 259 · see citing works
Cancer proteogenomics: current impact and future prospects
Mani, D. R., Krug, K., Zhang, B., Satpathy, S., Clauser, K. R., Ding, L., Ellis, M., Gillette, M. A., & Carr, S. A. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00446-5 · Cited by 229 · see citing works
Self-citationA high-stringency blueprint of the human proteome
Adhikari, S., Nice, E. C., Deutsch, E. W., Lane, L., Omenn, G. S., Pennington, S. R., Paik, Y.-K., Overall, C. M., Corrales, F. J., Cristea, I. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19045-9 · Cited by 210 · see citing works
Self-citationClinical potential of mass spectrometry-based proteogenomics
Zhang, B., Whiteaker, J. R., Hoofnagle, A. N., Baird, G. S., Rodland, K. D., & Paulovich, A. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0135-7 · Cited by 210 · see citing works
Self-citationTissue-Specific Oncogenic Activity of KRASA146T
Poulin, E. J., Bera, A. K., Lu, J., Lin, Y.-J., Strasser, S. D., Paulo, J. A., Huang, T. Q., Morales, C., Yan, W., Cook, J., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1220 · Cited by 197 · see citing works
The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron
Ichikawa, S., Flaxman, H. A., Xu, W., Vallavoju, N., Lloyd, H. C., Wang, B., Shen, D., Pratt, M. R., & Woo, C. M. (2022) · Nature · doi:10.1038/s41586-022-05333-5 · Cited by 195 · see citing works
Trinh, A., Trumpi, K., De Sousa E Melo, F., Wang, X., de Jong, J. H., Fessler, E., Kuppen, P. J. K., Reimers, M. S., Swets, M., Koopman, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0680 · Cited by 180 · see citing works
Self-citationTang, W., Zhou, M., Dorsey, T. H., Prieto, D. A., Wang, X. W., Ruppin, E., Veenstra, T. D., & Ambs, S. (2018) · Genome Medicine · doi:10.1186/s13073-018-0602-x · Cited by 162 · see citing works
“Concordances between protein-mRNA pairs in breast cancer cell lines have been examined, and a mean correlation score of ~ for 94 pairs can be estimated from the study by Kennedy et al. [7]. tumors and 0.47 for colorectal tumor [13, 16].”
InfluentialSelf-citationVellinga, T. T., den Uil, S., Rinkes, I. H. B., Marvin, D., Ponsioen, B., Alvarez-Varela, A., Fatrai, S., Scheele, C., Zwijnenburg, D. A., Snippert, H., et al. (2016) · Oncogene · doi:10.1038/onc.2016.60 · Cited by 115 · see citing works
McDermott, J. E., Arshad, O. A., Petyuk, V. A., Fu, Y., Gritsenko, M. A., Clauss, T. R., Moore, R. J., Schepmoes, A. A., Zhao, R., Monroe, M. E., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100004 · Cited by 97 · see citing works
Self-citationGenetic control of the human brain proteome
Robins, C., Wingo, A. P., Fan, W., Duong, D. M., Meigs, J., Gerasimov, E. S., Dammer, E. B., Cutler, D. J., Jager, P. L. D., Bennett, D. A., et al. (2019) · doi:10.1101/816652 · Cited by 104 · see citing works
Wang, X., Codreanu, S. G., Wen, B., Li, K., Chambers, M. C., Liebler, D. C., & Zhang, B. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000155 · Cited by 97 · see citing works
Self-citationLee, T.-Y., Huang, K.-Y., Chuang, C.-H., Lee, C.-Y., & Chang, T.-H. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107277 · Cited by 95 · see citing works
Amoedo, N. D., Obre, E., & Rossignol, R. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.005 · Cited by 76 · see citing works
A framework for ultra-low-input spatial tissue proteomics
Makhmut, A., Qin, D., Fritzsche, S., Nimo, J., König, J., & Coscia, F. (2023) · Cell Systems · doi:10.1016/j.cels.2023.10.003 · Cited by 67 · see citing works
Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
Dai, J., Johnson, E. C. B., Dammer, E. B., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., Wingo, T. S., & Seyfried, N. T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00454 · Cited by 62 · see citing works
Brubaker, D. K., Paulo, J. A., Sheth, S., Poulin, E. J., Popow, O., Joughin, B. A., Strasser, S. D., Starchenko, A., Gygi, S. P., Lauffenburger, D. A., et al. (2019) · Cell Systems · doi:10.1016/j.cels.2019.07.006 · Cited by 57 · see citing works
“From CRC tumors, 53 proteomic and 224 mutation profiles were used (Cancer Genome Atlas, 2012; Zhang et al., 2014).”
MethodLi, C., Singh, B., Graves-Deal, R., Ma, H., Starchenko, A., Fry, W. H., Lu, Y., Wang, Y., Bogatcheva, G., Khan, M. P., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618297114 · Cited by 47 · see citing works
Self-citationGenetic Alterations of Metastatic Colorectal Cancer
Testa, U., Castelli, G., & Pelosi, E. (2020) · Biomedicines · doi:10.3390/biomedicines8100414 · Cited by 44 · see citing works
Tian, S., Zhan, D., Yu, Y., Wang, Y., Liu, M., Tan, S., Li, Y., Song, L., Qin, Z., Li, X., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-03048-y · Cited by 43 · see citing works
Self-citationTeyssonnière, E. M., Trébulle, P., Muenzner, J., Loegler, V., Ludwig, D., Amari, F., Mülleder, M., Friedrich, A., Hou, J., Ralser, M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319211121 · Cited by 40 · see citing works
Proteogenomics: emergence and promise
Faulkner, S., Dun, M. D., & Hondermarck, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1837-y · Cited by 36 · see citing works
The Impact of Cancer Stem Cells in Colorectal Cancer
Radu, P., Zurzu, M., Tigora, A., Paic, V., Bratucu, M., Garofil, D., Surlin, V., Munteanu, A. C., Coman, I. S., Popa, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084140 · Cited by 30 · see citing works
Oncogenic KRAS creates an aspartate metabolism signature in colorectal cancer cells
Doubleday, P. F., Fornelli, L., Ntai, I., & Kelleher, N. L. (2021) · The FEBS Journal · doi:10.1111/febs.16111 · Cited by 23 · see citing works
Ressa, A., Bosdriesz, E., de Ligt, J., Mainardi, S., Maddalo, G., Prahallad, A., Jager, M., de la Fonteijne, L., Fitzpatrick, M., Groten, S., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000486 · Cited by 17 · see citing works
Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases
Zhao, S., Wang, R., Song, S., Hao, D., Han, G., Song, X., Zhang, J., Pizzi, M. P., Shanbhag, N., Futreal, A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106913 · Cited by 5 · see citing works
- Authors
- CPTAC, T. N., Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., Kim, S., Davies, S. R., Wang, S., Wang, P., Kinsinger, C. R., Rivers, R. C., Rodriguez, H., Townsend, R. R., Ellis, M. J. C., Carr, S. A., Tabb, D. L., Coffey, R. J., Slebos, R. J. C., & Liebler, D. C.
- Affiliations
- Vanderbilt University (US)
- Pacific Northwest National Laboratory (US)
- Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
- Fred Hutch Cancer Center (US)
- National Institutes of Health (US)
- Washington University in St. Louis (US)
- Harvard University (US)
- Broad Institute (US)
- Corresponding author
- Liebler, Daniel C.
- ORCID
- Zhang, Bing
- Wang, Xiaojing
- Zhu, Jing
- Liu, Qi
- Shi, Zhiao
- Chambers, Matthew C.
- Zimmerman, Lisa J.
- Kim, Sangtae
- Davies, Sherri R.
- Wang, Pei
- Kinsinger, Christopher R.
- Rivers, Robert C.
- Rodriguez, Henry
- Townsend, R. Reid
- Ellis, Matthew J. C.
- Carr, Steven A.
- Tabb, David L.
- Coffey, Robert J.
- Slebos, Robbert J. C.
- Liebler, Daniel C.
- Venue
- Nature
- Published
- 2014-07-20
- Volume
- 513
- Issue
- 7518
- Pages
- 382-387
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4249766
- OpenAlex
- W2131856634
- Cited by
- 1,462
- References
- 81
- Citations by year
- 2026: 76 · 2025: 85 · 2024: 85 · 2023: 117 · 2022: 163 · 2021: 152 · 2020: 132 · 2019: 132 · 2018: 124 · 2017: 139 · 2016: 116 · 2015: 113 · 2014: 26
- FWCI
- 42.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- PMC
- Funders
- National Institutes of Health (5u24ca160035-05, UL1TR000448)
- National Human Genome Research Institute (U54HG003079)
- National Cancer Institute (U24CA159988, U24-CA-160035, P50CA095103, U24CA160019, U24CA160034, R01CA046413, P30CA068485)
- National Institute of General Medical Sciences (GM088822, R01GM088822)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK058404)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- colorectal cancer, proteogenomics, protein abundance, proteomic subtypes, copy number alterations, mRNA-protein correlation, driver genes, HNF4α, TOMM34, Src kinase, microsatellite instability, CpG island methylation, clinical outcomes, somatic mutations
- MeSH terms
- Proto-Oncogene Mas, Mitochondrial Precursor Protein Import Complex Proteins, Chromosomes, Human, Pair 20, Colonic Neoplasms, Humans, Neoplasm Proteins, Rectal Neoplasms, RNA, Messenger, RNA, Neoplasm, Proto-Oncogene Proteins pp60(c-src), Point Mutation, Microsatellite Repeats, CpG Islands, DNA Methylation, Mutation, Missense, Proteome, Genomics, Mitochondrial Membrane Transport Proteins, Proteomics, Hepatocyte Nuclear Factor 4, DNA Copy Number Variations, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review